NASOPHARYNGEAL CARCINOMA (NPC)
Clinical trials for NASOPHARYNGEAL CARCINOMA (NPC) explained in plain language.
Never miss a new study
Get alerted when new NASOPHARYNGEAL CARCINOMA (NPC) trials appear
Sign up with your email to follow new studies for NASOPHARYNGEAL CARCINOMA (NPC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Advanced cancer trial tests if proton therapy reduces harsh side effects
Disease control Recruiting nowThis study is testing whether a newer type of radiation called proton therapy causes fewer severe side effects than standard photon radiation for people with advanced nasopharyngeal cancer. All 300 participants will receive chemotherapy and immunotherapy, and then be randomly ass…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE3 • Sponsor: Man Hu • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Cancer trial aims to cut radiation damage while boosting immune power
Disease control Recruiting nowThis study is for people newly diagnosed with nasopharyngeal cancer that has spread. It compares two radiation approaches given after chemotherapy and immunotherapy. One approach targets a smaller area to try to reduce side effects and possibly help the immune system work better.…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE3 • Sponsor: Ming-Yuan Chen • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New combo therapy aims to tame Tough-to-Treat head & neck cancer recurrence
Disease control Recruiting nowThis study is testing a two-part treatment for recurrent nasopharyngeal cancer (a type of head and neck cancer) in patients who are not candidates for surgery. First, patients receive a short course of targeted radiation combined with an immunotherapy drug. After a break, they re…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE2 • Sponsor: Jiangxi Provincial Cancer Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New hope for advanced throat cancer patients in major trial
Disease control Recruiting nowThis study is testing whether a new combination of drugs works better than standard treatment for advanced nasopharyngeal cancer (a type of throat cancer). Researchers will compare a new treatment approach using two targeted drugs with the current standard chemotherapy. The trial…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE3 • Sponsor: First Affiliated Hospital of Guangxi Medical University • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New drug trial offers hope for advanced throat cancer patients out of options
Disease control Recruiting nowThis study is testing an experimental drug called HLX43 for people with advanced nasopharyngeal cancer (a type of throat cancer) that has returned or spread and hasn't responded to at least two previous treatments. The trial will enroll 70 participants to receive one of three dif…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE2 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Could less radiation mean fewer side effects for throat cancer patients?
Disease control Recruiting nowThis study is for people with advanced nasopharyngeal (upper throat) cancer who have already responded well to initial drug treatments. It aims to see if using a lower dose of radiation therapy works as well as the standard dose at keeping the cancer from returning, while hopeful…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE3 • Sponsor: Ming-Yuan Chen • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Three-Drug attack on tough Head/Neck cancer shows promise
Disease control Recruiting nowThis study is testing a new combination of three immunotherapy drugs for people with advanced nasopharyngeal carcinoma (a type of head and neck cancer) that has come back or spread after their first treatment stopped working. The goal is to see if this three-drug approach is more…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
Personalized radiation could spare patients harsh side effects in head & neck cancer trial
Disease control Recruiting nowThis study is testing if a more personalized radiation plan for the neck is as good at preventing cancer from coming back as the standard, broader radiation approach. It will involve 462 adults with nasopharyngeal carcinoma (a type of head and neck cancer) that hasn't spread to d…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE3 • Sponsor: Fudan University • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC
-
New inhaler could ease agonizing mouth sores for cancer patients
Symptom relief Recruiting nowThis study is testing whether a medication called Sapylin, inhaled as a mist, works as well as the standard steroid dexamethasone to prevent and reduce severe mouth sores caused by combined chemotherapy and radiation for nasopharyngeal cancer. Researchers will enroll 180 patients…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE3 • Sponsor: Affiliated Hospital of Guangdong Medical University • Aim: Symptom relief
Last updated Mar 23, 2026 15:19 UTC
-
New scan tested to personalize cancer treatment
Knowledge-focused Recruiting nowThis study is testing a new type of PET scan to see if it can help doctors select the best treatment for patients with a specific type of head and neck cancer (nasopharyngeal carcinoma). Researchers will give the scan to 10 patients before and after starting chemotherapy or radia…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE1, PHASE2 • Sponsor: University Medical Center Groningen • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:31 UTC